首页> 外文期刊>Diabetes/metabolism research and reviews >Identification of a distinct phenotype of elderly latent autoimmune diabetes in adults: LADA China Study 8
【24h】

Identification of a distinct phenotype of elderly latent autoimmune diabetes in adults: LADA China Study 8

机译:鉴定成人老年人潜在自身免疫糖尿病明显表型:LADA中国研究8

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetes has become a serious urgent public health problem in China at present. One out of every 10 Chinese suffers from diabetes, and China has more than 100 million of adults with diabetes, which is more than any other country in the world.1 Latent autoimmune diabetes in adult (LADA) is defined as initially noninsulin requiring diabetes with associated autoantibodies like glutamic acid decarboxylase autoantibody (GADA) and so on. Patients with LADA are at high risk of progression to insulin dependency.2 LADA accounts for 2.6% to 12% of all patients with diabetes, which differs significantly in different ethnic groups.3-6 Our previous study has shown that around 5.9% of diabetic patients were classified as LADA in China.7 According to the population epidemiological survey, it can be speculated that China has the largest number of LADA patients, which are more than 6 million.8 Because of its high prevalence, LADA represents an important clinical issue that should need to be further addressed.
机译:糖尿病目前已成为中国的严重紧急公共卫生问题。每10例中国人患有糖尿病,而中国拥有超过1亿名患有糖尿病的成年人,这比世界上任何其他国家都有比成人(LADA)的潜在自身免疫性糖尿病(Lada)的糖尿病患者最初被定义为初始非胰岛素需要糖尿病相关的自身抗体,如谷氨酸脱羧酶自身抗体(GADA)等。患有患者的患者对胰岛素依赖的进展高。患者被归类为中国拉达.7根据人口流行病学调查,可以推测中国拥有最多的拉达患者,这些患者超过600万.8,因为它的普及率高,LADA代表着一个重要的临床问题。应该需要进一步解决。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号